Answers are grounded in this paper and cite their sources.
Metabolic syndrome is associated with increased propensity for diabetes and cardiovascular disease. Low-grade inflammation is characteristic of metabolic syndrome. C-reactive protein, the best characterized biomarker of inflammation, is also an independent predictor of future cardiovascular events. This review outlines the role of high-sensitivity C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome by inducing endothelial cell dysfunction and activating monocytes.
No takes yet. Share an insight, caveat, or question.
Devaraj et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: